Clinical Trial

An International Study on Pediatric Patients With Rare Tumors.

Study acronym: PARTNER
Recruiting
View on ClinicalTrials.gov →
Summary
The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.
Trial Details
NCT Number NCT07072143
Lead Sponsor Azienda Ospedaliera di Padova
Collaborators: St. Anna Children's Hospital, Vienna, Children's Hospital Zagreb, Centre Hospitalier Universitaire de La Réunion, FRANCE, Klinikum Dortmund, University Children's Hospital Tuebingen, Hellenic Oncology Research Group, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Kaplan Medical Center, Rehovot, Israel, Vilnius University Hospital Santaros Klinikos, University of Skopje, Gdansk Medical University (Poland), Centro Hospitalar do Porto, Bucharest Emergency Hospital, Institute for Oncology and Radiology Serbia, Belgrade, University Hospital Bratislava, University Medical Centre Ljubljana, University of Bilbao, Göteborg University, University Hospital, Paris
Conditions Paraganglioma/ Phaeochromocytoma, Melanoma and Other Malignant Neoplasms of Skin, Gastrointestinal Stromal Tumor (GIST), Adrenocortical Tumor, Pancreatic Tumors, Esthesioneuroblastoma, Olfactory, Mesothelioma, Nasopharyngeal Carcinoma (NPC) +6 more
Enrollment 6,250 participants
Start Date 2025-01-25
Primary Completion 2049-01-06 (estimated)
Study Completion 2049-06-06 (estimated)
Updated on ClinicalTrials.gov 2025-07-18